| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/22/2009 | WO2009033736A3 Use of met-enkephalin as a therapeutic agent |
| 05/22/2009 | WO2009033735A3 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents |
| 05/22/2009 | WO2009033669A3 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent |
| 05/22/2009 | WO2008034032A3 Beta-lactam cannabinoid receptor modulators |
| 05/22/2009 | CA2743334A1 Methods relating to breathing disorders |
| 05/22/2009 | CA2705916A1 Benzazepinone compound |
| 05/22/2009 | CA2705562A1 Isoquinoline modulators of atp-binding cassette transporters |
| 05/22/2009 | CA2705539A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 05/22/2009 | CA2703600A1 N-containing heterocyclic compounds |
| 05/21/2009 | US20090131513 Anti-inflammatory modalities |
| 05/21/2009 | US20090131497 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 05/21/2009 | US20090131492 Indole derivatives as CFTR modulators |
| 05/21/2009 | US20090131486 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial |
| 05/21/2009 | US20090131483 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 05/21/2009 | US20090131467 Heterocycle Compound, and Production Process and Application Thereof |
| 05/21/2009 | US20090131458 Compounds |
| 05/21/2009 | US20090131457 Pyrazolo [3,4-D] Pyrimidine Derivatives Useful to Treat Respiratory Disorders |
| 05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
| 05/21/2009 | US20090131439 Therapeutic agent for chronic obstructive pulmonary disease |
| 05/21/2009 | US20090131424 Thiazolyl-dihydro-chinazoline |
| 05/21/2009 | US20090131347 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a th1 phenotype |
| 05/21/2009 | US20090131317 Compounds and peptides that bind the trail receptor |
| 05/21/2009 | US20090131305 Alpha-1 antitrypsin for treating exacerbation episodes of pulmonary diseases |
| 05/21/2009 | US20090130216 Multimodal particulate formulations |
| 05/21/2009 | US20090130199 Preparations, Methods And Kits Useful For The Treatment of Cough |
| 05/21/2009 | US20090130126 Dna expression vectors |
| 05/21/2009 | US20090130093 Binding member for gm-csf receptor |
| 05/21/2009 | US20090130077 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 05/21/2009 | US20090130026 Pharmaceutical solution formulations for pressurised metered dose inhalers |
| 05/20/2009 | EP2060575A1 Dihydrothienopyrimidines and their use in treating inflammatory diseases |
| 05/20/2009 | EP2060572A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 05/20/2009 | EP2060563A1 Cyclic aminoalkylcarboxamide derivative |
| 05/20/2009 | EP2060258A1 Use of CRTH2 antagonist compounds in therapy |
| 05/20/2009 | EP2060255A2 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
| 05/20/2009 | EP2059505A2 Muscarinic receptor antagonists |
| 05/20/2009 | EP2059249A2 Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases |
| 05/20/2009 | EP1915166B1 Marrubiin and composition for reducing snoring, package and method |
| 05/20/2009 | EP1365760B1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 05/20/2009 | DE60226032T2 Neue imidazolidinderivate, deren herstellung und verwendung als vla4-antagonisten New imidazolidine derivatives, their preparation and use as VLA4 antagonists |
| 05/20/2009 | CN201239400Y Pocket type gauze mask for preventing respiratory infectious disease |
| 05/20/2009 | CN201238613Y Underwear with medicament interlayer |
| 05/20/2009 | CN101437835A Short interference ribonucleic acids for treating allergic diseases |
| 05/20/2009 | CN101437797A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 05/20/2009 | CN101437796A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 05/20/2009 | CN101437795A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them |
| 05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 05/20/2009 | CN101433709A Decoction for treating cough |
| 05/20/2009 | CN101433703A Medicinal granules for treating common cold and formulating method thereof |
| 05/20/2009 | CN101433702A Health-care wine for preventing avian influenza and formulating method thereof |
| 05/20/2009 | CN101433697A Chinese medicinal prescription for treating respiratory tract infection and wind-heat dry cough |
| 05/20/2009 | CN101433682A Medicine for treating pulmonary tuberculosis and preparation method thereof |
| 05/20/2009 | CN101433681A Pure Chinese medicine for resisting tuberculosis |
| 05/20/2009 | CN101433673A Cold treating medicine |
| 05/20/2009 | CN101433672A Chinese medicament preparation for treating nosebleed and preparation method thereof |
| 05/20/2009 | CN101433669A Use of pharmaceutical composition in preparing medicament for preventing and treating allergic diseases |
| 05/20/2009 | CN101433663A Chinese medicine for treating cough |
| 05/20/2009 | CN101433621A Chinese medicinal composition for treating asthma of pig as well as preparation method and use thereof |
| 05/20/2009 | CN101433609A Use of pharmaceutical composition in preparing medicament for preventing and treating allergic diseases |
| 05/20/2009 | CN101433594A Sugar-free honeysuckle flower common cold granule |
| 05/20/2009 | CN101433580A Chinese medicine medicinal granules for treating acute and chronic bronchial asthma |
| 05/20/2009 | CN101433555A Chinese medicine for treating children's cough and preparation method thereof |
| 05/20/2009 | CN101433541A Pharmaceutical composition containing beta2 agonists and steroids, and uses thereof |
| 05/20/2009 | CN101433529A Glycyrrhizic acid transdermal formulation and preparation technique thereof |
| 05/20/2009 | CN101433527A Use of plant capsule in powder spray |
| 05/20/2009 | CN100488973C High efficiency extracting method for sophora alopecuroide total alkaloid |
| 05/20/2009 | CN100488964C N2-arylformyl-4-ammonia/amidopteridine compound capable of regulating nitrous oxide synthase acitivity |
| 05/20/2009 | CN100488948C N-substituted indole-3-acetaldehyde amide compound with anti-asthma, anti-amaphylactic and immunosupression/immunoregulation action |
| 05/20/2009 | CN100488564C Preventives/remedies for snore or respiratory disturbances during sleep |
| 05/20/2009 | CN100488562C Clotting factor VII or VIIa like molecules |
| 05/20/2009 | CN100488533C An herbal composition for the treatment and remedy of bronchial respiratory difficulties |
| 05/20/2009 | CN100488530C Chinese herbal medicine recipe for treating asthma |
| 05/20/2009 | CN100488497C Use of leukotriene in preparing medicament |
| 05/19/2009 | US7534897 Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism |
| 05/19/2009 | US7534884 Preparation of pharmaceutical salts |
| 05/19/2009 | US7534800 pyrrolo[2,3-b]pyridine derivatives; treatment of neurodegenerative disorders related to apoptosis and/or inflammation; compound prepared by condensation, halogenation, hydrogenation, using silan protected drivatives |
| 05/19/2009 | US7534440 Fusion molecules and methods for treatment of immune diseases |
| 05/19/2009 | CA2463947C Montelukast granule formulation |
| 05/19/2009 | CA2395969C Novel tetrahydropyridines, method for the preparation thereof and pharmaceutical compositions containing them |
| 05/19/2009 | CA2368059C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 05/14/2009 | WO2009062193A2 Methods for administering corticosteroid formulations |
| 05/14/2009 | WO2009062118A2 Modulation of protein trafficking |
| 05/14/2009 | WO2009061852A2 Modulation of factor 9 expression |
| 05/14/2009 | WO2009061851A2 Modulation of factor 7 expression |
| 05/14/2009 | WO2009061447A2 Use of umbilical cord blood in the treatment of premature birth complications |
| 05/14/2009 | WO2009061271A1 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/14/2009 | WO2009060278A1 Cyclobutyl carboxylic acid derivatives |
| 05/14/2009 | WO2009060209A1 6,6-fused bicyclic aromatic compounds and their therapeuti use |
| 05/14/2009 | WO2009060203A1 3,4,6,7-tetrahydro-1 h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use |
| 05/14/2009 | WO2009059893A1 Crystalline hydrate of betamimetika and use as medicament thereof |
| 05/14/2009 | WO2009059425A1 Stat3 inhibitors for the treatment of fibrosis |
| 05/14/2009 | WO2009040083A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009040047A3 Therapeutic uses of ghrelin and combinations with stresscopin |
| 05/14/2009 | WO2009040033A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009040019A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009039986A3 Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-αrg as a therapeutic agent |
| 05/14/2009 | WO2009033807A3 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43 |
| 05/14/2009 | WO2009033804A3 Use of gamma- endorphin as a therapeutic agent |
| 05/14/2009 | WO2009033803A3 Use of the pentapeptide drlds and gamma-endorphin as therapeutic agents |
| 05/14/2009 | WO2009033799A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009033754A8 Use of a peptide as a therapeutic agent |